ASGCT presentation by Kevin Hollevoet


On May 13th, our colleague Kevin Hollevoet presented his KU Leuven work at the 23rd Annual Meeting of the American Society of Gene & Cell Therapy. The presentation, entitled “Building a Versatile and Clinically Translatable Platform for DNA-Based Antibody Therapeutics”, gave an overview of the key milestones of the KU Leuven Antibody Gene Transfer Program, focusing on the in vivo production of antibodies and Nanobodies, in mice and sheep, using either intramuscular or intratumoral electroporation. The recording of his talk is available via: